Literature DB >> 34110477

Vascularized fibular grafts for the treatment of long bone defects: pros and cons. A systematic review and meta-analysis.

Christian Candrian1,2, Giuseppe Filardo3,2, Pietro Feltri1, Luca Solaro4, Costantino Errani5, Guglielmo Schiavon1.   

Abstract

PURPOSE: To quantify union rate, complication rate, reintervention rate, as well as functional outcome after vascularized fibular bone grafts (VFGs) for the treatment of long-bone defects.
METHODS: A comprehensive search was performed in the PubMed, Web of Science, and Cochrane databases up to August 18, 2020. Randomized controlled trials, comparative studies, and case series describing the various techniques available involving VFGs for the reconstruction of segmental long-bone defects were included. A meta-analysis was performed on union results, complications, and reinterventions. Assessment of risk of bias and quality of evidence was performed with the Downs and Black's "Checklist for Measuring Quality".
RESULTS: After full-text assessment, 110 articles on 2226 patients were included. Among the retrieved studies, 4 were classified as poor, 83 as fair, and 23 as good. Overall, good functional results were documented and a union rate of 80.1% (CI 74.1-86.2%) was found, with a 39.4% (CI 34.4-44.4%) complication rate, the most common being fractures, non-unions and delayed unions, infections, and thrombosis. Donor site morbidity represented 10.7% of the total complications. A 24.6% reintervention rate was documented (CI 21.0-28.1%), and 2.8% of the patients underwent amputation.
CONCLUSIONS: This systematic review and meta-analysis documented good long-term outcomes both in the upper and lower limb. However, VFG is a complex and demanding technique; this complexity means an average high number of complications, especially fractures, non-unions, and vascular problems. Both potential and limitations of VFG should be considered when choosing the most suitable approach for the treatment of long-bone defects.

Entities:  

Keywords:  Bone implant; Free graft; Long-bone defects; Pedicled; VFG; Vascularized fibular grafts

Year:  2021        PMID: 34110477     DOI: 10.1007/s00402-021-03962-5

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  70 in total

Review 1.  Bone substitutes: an update.

Authors:  Peter V Giannoudis; Haralambos Dinopoulos; Eleftherios Tsiridis
Journal:  Injury       Date:  2005-11       Impact factor: 2.586

2.  Reconstruction of large skeletal defects by vascularized fibula transfer. Factors that influenced the outcome of union in 62 cases.

Authors:  H H de Boer; M B Wood; J Hermans
Journal:  Int Orthop       Date:  1990       Impact factor: 3.075

3.  The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions.

Authors:  S H Downs; N Black
Journal:  J Epidemiol Community Health       Date:  1998-06       Impact factor: 3.710

Review 4.  Vascularized fibula transfer for lower limb reconstruction.

Authors:  Alexandros E Beris; Marios G Lykissas; Anastasios V Korompilias; Marios D Vekris; Gregory I Mitsionis; Konstantinos N Malizos; Panayiotis N Soucacos
Journal:  Microsurgery       Date:  2011-02-25       Impact factor: 2.425

5.  Reconstruction of post-traumatic long segment bone defects of the lower end of the femur by free vascularized fibula combined with allograft (modified Capanna's technique).

Authors:  H Venkatramani; S R Sabapathy; J Dheenadayalan; A Devendra; S Rajasekaran
Journal:  Eur J Trauma Emerg Surg       Date:  2014-09-23       Impact factor: 3.693

6.  Combined Massive Allograft and Intramedullary Vascularized Fibula as the Primary Reconstruction Method for Segmental Bone Loss in the Lower Extremity: A Systematic Review and Meta-Analysis.

Authors:  Rudolph H Houben; Mathijs Rots; Stefanie C M van den Heuvel; Henri A H Winters
Journal:  JBJS Rev       Date:  2019-08

7.  The free vascularized fibular graft for bridging large skeletal defects of the upper extremity.

Authors:  Panayotis N Soucacos; Anastasios V Korompilias; Marios D Vekris; Aristides Zoubos; Alexandros E Beris
Journal:  Microsurgery       Date:  2011-03-03       Impact factor: 2.425

8.  Free vascularized fibular grafts for large bone defects in the extremities after tumor excision.

Authors:  K Ihara; K Doi; M Yamamoto; S Kawai
Journal:  J Reconstr Microsurg       Date:  1998-08       Impact factor: 2.873

9.  Vascularised free fibular flap in bone resection and reconstruction.

Authors:  P J Belt; I C Dickinson; D R B Theile
Journal:  Br J Plast Surg       Date:  2005-06

Review 10.  Free fibula osteoseptocutaneous graft for reconstruction of segmental femoral shaft defects.

Authors:  F C Wei; T A El-Gammal; C H Lin; W N Ueng
Journal:  J Trauma       Date:  1997-11
View more
  4 in total

1.  Union, complication, reintervention and failure rates of surgical techniques for large diaphyseal defects: a systematic review and meta-analysis.

Authors:  Pietro Feltri; Luca Solaro; Alessandro Di Martino; Christian Candrian; Costantino Errani; Giuseppe Filardo
Journal:  Sci Rep       Date:  2022-06-01       Impact factor: 4.996

2.  Evaluation of the efficacy of ipsilateral fibular transfer for reconstruction of large tibial defects in children: a retrospective study.

Authors:  SiYu Xu; YaoXi Liu; GuangHui Zhu; Kun Liu; Jin Tang; JiangYan Wu; An Yan; Fei Jiang; ShaSha Mo; HaiBo Mei
Journal:  J Orthop Surg Res       Date:  2022-03-05       Impact factor: 2.359

3.  Cross-sectional Vascularization Pattern of the Adipofascial Anterolateral Thigh Flap for Application in Tissue-engineered Bone Grafts.

Authors:  Joel Buergin; Lucas Werth; René Largo; Arnaud Scherberich; Dirk J Schaefer; Alexandre Kaempfen
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-02-22

4.  Treatment of persistent large cystic lesions of the humerus with vascularized fibular grafts.

Authors:  Mehmet Ümit Çetin; İsmail Bülent Özçelik
Journal:  Jt Dis Relat Surg       Date:  2022-07-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.